JP2010110386A - Medical multi-chamber container - Google Patents

Medical multi-chamber container Download PDF

Info

Publication number
JP2010110386A
JP2010110386A JP2008283603A JP2008283603A JP2010110386A JP 2010110386 A JP2010110386 A JP 2010110386A JP 2008283603 A JP2008283603 A JP 2008283603A JP 2008283603 A JP2008283603 A JP 2008283603A JP 2010110386 A JP2010110386 A JP 2010110386A
Authority
JP
Japan
Prior art keywords
chamber container
chemical solution
medical multi
chemical
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008283603A
Other languages
Japanese (ja)
Other versions
JP5133849B2 (en
Inventor
Toshiharu Iwasaki
年晴 岩崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hosokawa Yoko KK
Original Assignee
Hosokawa Yoko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hosokawa Yoko KK filed Critical Hosokawa Yoko KK
Priority to JP2008283603A priority Critical patent/JP5133849B2/en
Priority to PCT/JP2009/005623 priority patent/WO2010052844A1/en
Publication of JP2010110386A publication Critical patent/JP2010110386A/en
Application granted granted Critical
Publication of JP5133849B2 publication Critical patent/JP5133849B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Package Specialized In Special Use (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a medical multi-chamber container capable of being manufactured without the need of a complicated process or a difficult technique, and preventing the erroneous administration of a liquid chemical before being mixed even while handleability is excellent. <P>SOLUTION: White printing is performed to at least one of a pair of transparent films 11a and 11b in an area to be below a liquid surface L<SB>1</SB>positioned highest among the respective liquid surfaces of the respective liquid chemicals inside a plurality of liquid chemical storage chambers 12a and 12b before opening a weakly sealed part 12c and to be equal to or above the liquid surface L<SB>M</SB>of a liquid chemical mixture for which the respective liquid chemicals are mixed after opening the weakly sealed part 12c when hanging the medical multi-chamber container so that a liquid chemical discharge port 14 is at the lower part. Also, when viewing the medical multi-chamber container 10A from the front, in an area P including at least the white printing, fine recessed and projected surface treatment is performed to the inner surface of at least one of the pair of transparent films 11a and 11b. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、複数の薬液収納室を有し、これら薬液収納室内の薬液を使用直前に混合して、点滴などに使用する医療用複室容器に関する。   The present invention relates to a medical multi-chamber container that has a plurality of chemical solution storage chambers and mixes the chemical solutions in the chemical solution storage chambers immediately before use and uses them for infusion.

従来から、区画された複数の薬液収納室を有し、これら薬液収納室内の薬液を使用直前に混合して、点滴などに使用する医療用複室容器が知られている。複数の薬液収納室は、例えば、外部から医療用複室容器に圧力を加えることで剥離して開通する弱シール部などの仕切部により、液密に区画されている。そして、使用の直前に仕切部を開通させて薬液を混合した後、混合薬液を排出口から排出し、点滴などにより患者に投与している。   2. Description of the Related Art Conventionally, there is known a medical multi-chamber container that has a plurality of partitioned chemical solution storage chambers, mixes the chemical solutions in the chemical solution storage chambers immediately before use, and uses them for infusion. The plurality of chemical solution storage chambers are partitioned liquid-tightly by, for example, a partition portion such as a weak seal portion that is peeled off and opened by applying pressure to the medical multi-chamber container from the outside. And after opening a partition part just before use and mixing a chemical | medical solution, the mixed chemical | medical solution is discharged | emitted from a discharge port, and is administered to a patient by drip etc.

しかし、仕切部を開通し忘れ、本来混合調剤されるべき薬液が混合されず、混合前の一部の薬液のみを患者へ投与してしまう可能性がある。そこで、医療用複室容器に種々の対策をすることが検討されている。     However, forgetting to open the partition, the drug solution that should originally be mixed and dispensed may not be mixed, and only a part of the drug solution before mixing may be administered to the patient. Therefore, various measures for medical multi-chamber containers are being studied.

例えば、特許文献1には、複数の薬液収納室の他に、これら薬液収納室の1つに連通可能な分室が設けられ、この分室に連通するように薬液排出口が設けられた医療用複室容器が開示されている。この医療用複室容器は、薬液収納室同士を区画する仕切手段を開通させないと、薬液収納室と分室とを区画する閉鎖手段が開通しないように構成されている。そのため、この医療用複室容器によれば、混合前の薬液が誤って排出口から排出されることがない。また、特許文献2にも同様に、複数の薬液が混合されないと薬液排出口から薬液が排出されないように構成された医療用複室容器が提案されている。     For example, in Patent Document 1, in addition to a plurality of chemical solution storage chambers, there is provided a compartment capable of communicating with one of these chemical solution storage chambers, and a medical compound discharge port provided with a chemical solution discharge port so as to communicate with this compartment. A chamber container is disclosed. This medical multi-chamber container is configured so that the closing means for partitioning the chemical solution storage chamber and the compartment is not opened unless the partitioning means for partitioning the chemical solution storage chambers is opened. Therefore, according to this medical multi-chamber container, the chemical solution before mixing is not accidentally discharged from the discharge port. Similarly, Patent Document 2 proposes a medical multi-chamber container configured such that a chemical solution is not discharged from a chemical solution outlet unless a plurality of chemical solutions are mixed.

また、特許文献3には、薬液排出口を含む医療用複室容器の一部分を折曲状態で固定した医療用複室容器が開示されている。この医療用複室容器によれば、外部からの加圧により薬液収納室間を区画する弱シール部が開通され、同時に折曲状態が解除されてはじめて、薬液が排出可能となる。そのため、この医療用複室容器においても、複数の薬液が混合されないと、薬液排出口から薬液が排出されないようになっている。   Patent Document 3 discloses a medical multi-chamber container in which a part of a medical multi-chamber container including a chemical solution discharge port is fixed in a bent state. According to this medical multi-chamber container, the liquid medicine can be discharged only after the weak seal portion that partitions the liquid medicine storage chamber is opened by external pressurization and the bent state is released at the same time. Therefore, even in this medical multi-chamber container, the chemical solution is not discharged from the chemical solution discharge port unless a plurality of chemical solutions are mixed.

一方、特許文献4には、複数の薬液収納室を区画する弱シール部が剥離しているかどうか、容易に目視確認できるようにすることで、混合前の薬液の投与を防ごうとする医療用複室容器が提案されている。この医療用複室容器においては、弱シール部を構成する2枚のフィルムシート部分のそれぞれに視認可能な処理が施されていて、弱シール部の剥離前と剥離後とでは、弱シール部の外観が視覚的に異なるようにされている。
特開平9−327498号公報 特開2005−342174号公報 特開2007−282707号公報 特開2004−141631号公報
On the other hand, Patent Document 4 discloses a medical device intended to prevent the administration of a drug solution before mixing by enabling easy visual confirmation whether or not the weak seal portions that divide a plurality of drug solution storage chambers are peeled off. Multi-chamber containers have been proposed. In this medical multi-chamber container, a visible treatment is applied to each of the two film sheet portions constituting the weak seal portion, and the weak seal portion is separated before and after the weak seal portion is peeled off. The appearance is made visually different.
JP-A-9-327498 JP 2005-342174 A JP 2007-282707 A JP 2004-141631 A

しかしながら、特許文献1および2の医療用複室容器では、閉鎖手段をなす弱シール部と仕切手段をなす弱シール部とを形成するにあたって、これら弱シール部のシール強度を厳密に制御しなければならず、シール条件の微調整やフィルム材質の選定に留意する必要があった。また、特許文献3の医療用複室容器を製造する際には、医療用複室容器の一部分を折曲状態で固定する工程が必要であった。このように特許文献1〜3の医療用複室容器は、その製造工程が煩雑であった。
さらに、特許文献1および2の医療用複室容器は分室を有している点で、従来の一般的な医療用複室容器とは異なり、また、特許文献3の医療用複室容器はその一部分が折曲状態で固定されている点で、従来の一般的な医療用複室容器とは異なっている。そのため、特許文献1〜3の医療用複室容器を使用する場合には、各医療用複室容器に応じた方法で取り扱う必要があり、取扱性に劣るという問題もあった。
However, in the medical multi-chamber container of Patent Documents 1 and 2, when forming the weak seal portion that forms the closing means and the weak seal portion that forms the partition means, the seal strength of these weak seal portions must be strictly controlled. However, it was necessary to pay attention to fine adjustment of sealing conditions and selection of film materials. Moreover, when manufacturing the medical multi-chamber container of patent document 3, the process of fixing a part of medical multi-chamber container in the bending state was required. Thus, the manufacturing process of the medical multi-chamber container of Patent Documents 1 to 3 is complicated.
Furthermore, the medical multi-chamber container of Patent Documents 1 and 2 is different from the conventional general medical multi-chamber container in that it has a branch chamber. It differs from a conventional general medical multi-chamber container in that a part is fixed in a bent state. Therefore, when using the medical multi-chamber container of patent documents 1-3, it is necessary to handle by the method according to each medical multi-chamber container, and there also existed a problem that it was inferior to handleability.

一方、特許文献4の医療用複室容器では、弱シール部を構成する2枚のフィルムシート部分のそれぞれにあらかじめ印刷などで文様を付与しておき、その後、このように印刷された部分同士をヒートシールして弱シール部とする必要がある。この場合、印刷された文様部分に熱が加わるため、文様の形状などが乱れてしまう場合があり、文様の形状に影響を及ぼさずにヒートシールすることは技術的に難しいという問題があった。また、弱シール部のシール幅は通常10mm程度と狭いため、この部分に印刷などを施しても、弱シール部の剥離前なのか剥離後なのか、視覚的に判別しにくかった。   On the other hand, in the medical multi-chamber container of Patent Document 4, a pattern is given in advance to each of the two film sheet portions constituting the weak seal portion, and then the portions printed in this way are put together. It is necessary to heat seal to make a weak seal. In this case, since heat is applied to the printed pattern portion, the pattern shape and the like may be disturbed, and there is a problem that it is technically difficult to heat-seal without affecting the pattern shape. Further, since the seal width of the weak seal portion is usually as narrow as about 10 mm, even if printing or the like is applied to this portion, it is difficult to visually determine whether the weak seal portion is before or after peeling.

本発明は上記事情に鑑みてなされたもので、煩雑な工程や難しい技術を要せずに製造でき、取扱性も良好でありながら、混合前の薬液の誤投与を防ぐことのできる医療用複室容器を提供することを課題とする。   The present invention has been made in view of the above circumstances, and can be manufactured without requiring complicated processes and difficult techniques, while being easy to handle, it can prevent misadministration of a drug solution before mixing. It is an object to provide a chamber container.

本発明の医療用複室容器は、対向する一対の透明フィルムから形成され、開通可能な仕切部により区画された複数の薬液収納室が形成された容器本体と、前記複数の薬液収納室のうちの1つに連通して設けられた薬液排出口とを有する医療用複室容器であって、前記薬液排出口が下方となるように当該医療用複室容器を吊下げた場合に、前記仕切部の開通前には、前記複数の薬液収納室内の各薬液の各液面のうち最も上方に位置する液面よりも下方となり、前記仕切部の開通後には、前記各薬液が混合した混合薬液の液面よりも上方となる領域に、前記一対の透明フィルムのうちの少なくとも一方に白色印刷が施されているとともに、当該医療用複室容器を正面視した場合に前記白色印刷を少なくとも含む領域に、前記一対の透明フィルムのうちの少なくとも一方の内面に微細凹凸表面処理が施されていることを特徴とする。
前記白色印刷が施された側の透明フィルムに、前記微細凹凸表面処理が施されていることが好ましい。
The medical multi-chamber container of the present invention is formed of a pair of transparent films facing each other, and includes a container body in which a plurality of chemical solution storage chambers partitioned by an openable partition portion are formed, and the plurality of chemical solution storage chambers A medical multi-chamber container provided in communication with one of the medical multi-chamber containers, wherein when the medical multi-chamber container is suspended so that the medicinal liquid discharge port is downward, the partition Before the opening of the section, the liquid level is lower than the uppermost liquid level among the liquid levels of the chemical liquids in the plurality of chemical liquid storage chambers. In the region above the liquid level, white printing is applied to at least one of the pair of transparent films, and the region including at least the white printing when the medical multi-chamber container is viewed from the front. Of the pair of transparent films Wherein the fine uneven surface treatment on at least one of the inner surface is subjected Chino.
It is preferable that the fine uneven surface treatment is applied to the transparent film on which the white printing is performed.

本発明の医療用複室容器によれば、煩雑な工程や難しい技術を要せずに製造でき、取扱性も良好でありながら、混合前の薬液の誤投与を防ぐことができる。   According to the medical multi-chamber container of the present invention, it is possible to manufacture without requiring complicated processes and difficult techniques, and it is possible to prevent erroneous administration of the drug solution before mixing while being easy to handle.

以下、本発明の医療用複室容器について実施形態例を例示して、詳細に説明する。
図1は、本発明の医療用複室容器10Aの一例を示す正面図である。
この医療用複室容器10Aは、周縁部が剥離不能に融着された対向する一対の矩形の透明フィルム11a、11bから形成され、第1の薬液収納室12aと第2の薬液収納室12bとが長手方向に並べて形成された容器本体12を有する。第1の薬液収納室12aと第2の薬液収納室12bとの間には、開通可能な仕切部として、液密な弱シール部12cが直線状に形成され、この弱シール部12cにより、第1の薬液収納室12aと第2の薬液収納室12bとの間が区画されている。この医療用複室容器10Aは、第1の薬液収納室12aに第1薬液が収納され、第2の薬液収納室12bに第2薬液が収納された後、少なくともいずれか一方の薬液収納室12a、12bに対して外方から力を加えることによって、弱シール部12cが剥離、開通し、第1薬液と第2薬液とが混合され、混合薬液が容器本体12内で調製されるようになっている。なお、図1は、第1薬液および第2薬液のいずれもが収納されていない状態の医療用複室容器10Aを示している。
Hereinafter, the embodiment of the medical multi-chamber container of the present invention will be described in detail.
FIG. 1 is a front view showing an example of the medical multi-chamber container 10A of the present invention.
The medical multi-chamber container 10A is formed of a pair of opposing rectangular transparent films 11a and 11b whose peripheral portions are fused so as not to be peeled, and includes a first chemical solution storage chamber 12a and a second chemical solution storage chamber 12b. Has a container body 12 formed side by side in the longitudinal direction. Between the first chemical solution storage chamber 12a and the second chemical solution storage chamber 12b, a liquid-tight weak seal portion 12c is linearly formed as an openable partition portion. A space between the first chemical solution storage chamber 12a and the second chemical solution storage chamber 12b is defined. In the medical multi-chamber container 10A, after the first chemical solution is stored in the first chemical solution storage chamber 12a and the second chemical solution is stored in the second chemical solution storage chamber 12b, at least one of the chemical solution storage chambers 12a. By applying a force from the outside to 12b, the weak seal portion 12c is peeled and opened, the first chemical solution and the second chemical solution are mixed, and the mixed chemical solution is prepared in the container body 12. ing. FIG. 1 shows the medical multi-chamber container 10A in a state where neither the first chemical solution nor the second chemical solution is stored.

容器本体12の周縁部のうち、第1の薬液収納室12aが形成された側の長手方向の端部には、この医療用複室容器10Aを吊下げるための吊下げ穴13が形成されている。一方、第2の薬液収納室12bが形成された側の長手方向の端部には、第2の薬液収納室12bに連通して、針刺可能なゴム栓などで閉塞された中空状の薬液排出口14が設けられている。よって、弱シール部12cを開通させ、薬液排出口14が下方となるように、この医療用複室容器10Aの吊下げ穴13を点滴スタンドのフックなどに引掛け、ゴム栓に例えば点滴針を刺入れることにより、容器本体12内で調製された混合薬液が薬液排出口14から排出され、点滴などにより患者に投与されるようになっている。
なお、薬液排出口14は、第2の薬液収納室12bへ第2薬液を注入するための注入口としても使用される。また、第1の薬液収納室12aへの第1薬液の注入は、図示略の第1薬液注入口から行われる。
A suspension hole 13 for suspending the medical multi-chamber container 10A is formed at the longitudinal end of the peripheral portion of the container body 12 on the side where the first chemical solution storage chamber 12a is formed. Yes. On the other hand, at the end in the longitudinal direction on the side where the second chemical solution storage chamber 12b is formed, a hollow chemical solution that communicates with the second chemical solution storage chamber 12b and is closed by a needle plug that can be inserted into the needle. A discharge port 14 is provided. Accordingly, the weak seal portion 12c is opened, and the hanging hole 13 of the medical multi-chamber container 10A is hooked on the drip stand hook or the like so that the drug solution outlet 14 is located downward, and for example, a drip needle is attached to the rubber stopper. By inserting, the mixed chemical liquid prepared in the container main body 12 is discharged from the chemical liquid discharge port 14 and is administered to the patient by instillation or the like.
The chemical solution discharge port 14 is also used as an injection port for injecting the second chemical solution into the second chemical solution storage chamber 12b. Further, the first chemical liquid is injected into the first chemical liquid storage chamber 12a from a first chemical liquid injection port (not shown).

この例では、一対の透明フィルム11a、11bのうちの一方の透明フィルム11aにおける特定の領域に、弱シール部12cが未開通であることを示す「開通されていません」の文字からなるマークが白色印刷されている。
ここで白色印刷が施される特定の領域とは、図2に示すように、薬液排出口14が下方となるように、第1薬液と第2薬液とが収納された医療用複室容器10Aを点滴スタンドのフックFなどに吊下げた場合において、弱シール部12cの開通前(図2(a))には、各薬液収納室12a、12b内に収納された各薬液(この例では第1薬液と第2薬液)の各液面のうち、最も上方に位置する液面(この例では第1薬液の液面L)よりも下方となる領域であって、かつ、弱シール部12cの開通後(2(b))には、調製された混合薬液の液面Lよりも上方となる領域のことである。図2(a)中、Lは弱シール部12cの開通前における第2薬液の液面である。
In this example, in a specific region of one transparent film 11a of the pair of transparent films 11a and 11b, a mark composed of characters "not opened" indicating that the weak seal portion 12c is not opened. Printed in white.
As shown in FIG. 2, the specific area where white printing is performed is a medical multi-chamber container 10A in which the first chemical liquid and the second chemical liquid are accommodated so that the chemical liquid discharge port 14 is located below. Is hung on the drip stand hook F or the like before the weak seal portion 12c is opened (FIG. 2 (a)), each chemical solution stored in each chemical solution storage chamber 12a, 12b (in this example, the first Among the liquid levels of one chemical liquid and the second chemical liquid), the weak seal portion 12c is a region that is lower than the uppermost liquid level (in this example, the liquid level L 1 of the first chemical liquid). after the opening (2 (b)) is that of the upper and a region than the liquid level L M of the mixed drug solution prepared. In FIG. 2 (a), L 2 is a liquid level of the second chemical liquid before the opening of the weak seal portion 12c.

そして、さらに、上述の白色印刷を少なくとも含む領域(この例では図中実線で囲まれた矩形の領域P)において、白色印刷が施された側の透明フィルム11aの内面(薬液と接し、外気とは接しない側の面)に微細凹凸表面処理が施されている。
ここで微細凹凸表面処理は、透明フィルム11aの成形中または成形後に実施される。
成形中に処理する方法としては、溶融した樹脂をフィルム成形する成形機の出口部にスジまたは凹凸を設けることにより、ここから排出されるフィルムの表面にスジまたはすりガラス状の微細な凹凸を形成する方法がある。成形後に処理する方法としては、フィルム表面に例えば、サンドブラスト処理などのブラスト処理、金属ブラシなどによる凹凸付け処理などを施し、スジまたはすりガラス状の微細な凹凸を形成する方法が挙げられる。このように微細凹凸表面処理された表面は、薬液と接触していない場合には、微細凹凸のために光がその表面で複雑に反射、屈折するため、白く曇って見える。一方、薬液と接触すると、それにより表面が平滑になって光の反射、屈折が抑えられるため、透明に見える。
Further, in the region including at least the above-described white printing (in this example, a rectangular region P surrounded by a solid line in the drawing), the inner surface (in contact with the chemical solution, the outside air) of the transparent film 11a on the side on which the white printing is performed The surface not touching the surface is subjected to a fine uneven surface treatment.
Here, the fine irregular surface treatment is performed during or after the molding of the transparent film 11a.
As a method of processing during molding, by forming a streak or unevenness at the exit of a molding machine for forming a melted resin film, fine streaks such as stripes or ground glass are formed on the surface of the film discharged therefrom. There is a way. As a method of processing after forming, for example, a blasting process such as a sand blasting process, a concavo-convex process using a metal brush, or the like is performed on the film surface to form fine streaks such as stripes or ground glass. When the surface subjected to the surface treatment for fine irregularities is not in contact with a chemical solution, light is reflected and refracted on the surface in a complicated manner due to the fine irregularities, and thus appears white and cloudy. On the other hand, when it comes into contact with the chemical solution, the surface becomes smooth and reflection and refraction of light are suppressed, so that it looks transparent.

このような医療用複室容器10Aによれば、図2(a)に示すように、弱シール部12cの開通前には、「開通されていません」の文字からなる白色印刷は、第1薬液の液面Lよりも下方に位置している。また、微細凹凸表面処理が施されている領域Pも、この例ではその全体が第1薬液の液面Lよりも下方に位置している。
そのため、弱シール部12cの開通前には、微細凹凸表面処理が施されている領域Pの内面は、第1薬液と接触していて、使用者には透明に見える。よって、使用者は、透明に見える領域P内に施された白色印刷からなる「開通されていません」の文字をはっきりと視認することができ、この医療用複室容器10Aは弱シール部12cが開通されていないものであると明確に認識することができる。
According to such a medical multi-chamber container 10A, as shown in FIG. 2A, before the weak seal portion 12c is opened, the white print consisting of the characters “not opened” is the first It is located below the liquid level L 1 of the chemical. Also, regions P fine unevenness surface-treated, is positioned lower than its entirety in this example the liquid level L 1 of the first chemical liquid.
Therefore, before the opening of the weak seal portion 12c, the inner surface of the region P that has been subjected to the fine uneven surface treatment is in contact with the first chemical solution and appears transparent to the user. Therefore, the user can clearly see the letters “not opened” made of white printing applied in the transparent region P, and the medical multi-chamber container 10A has a weak seal portion 12c. Can be clearly recognized as not being opened.

ところが、図2(b)に示すように、弱シール部12cが開通すると、第1薬液と第2薬液とが混合されて混合薬液が調製され、その液面Lは、開通前の第1薬液の液面Lよりも低い位置になり、その結果、「開通されていません」の文字は混合薬液の液面Lよりも上方に位置するようになる。また、微細凹凸表面処理が施されている領域Pも、この例ではその全体が混合薬液の液面Lよりも上方に位置するようになる。
そのため、弱シール部12cの開通後には、微細凹凸表面処理が施されている領域Pの内面は薬液と接触しなくなり、この領域Pは使用者には全体が白く曇って見える。すなわち、領域Pの色は、「開通されていません」の文字と同じ白色に見えることになる。よって、使用者は、白く曇って見える領域P内に施された白色印刷からなる「開通されていません」の文字を視認しにくくなり、結果として、この医療用複室容器10Aが開通済みのものであると理解することができる。
However, as shown in FIG. 2 (b), when opening the weak seal portion 12c, the first chemical liquid and the second chemical liquid is being mixed chemical solution is prepared mixing, the liquid level L M is the first pre-opening It becomes lower position than the liquid level L 1 of the chemical, as a result, the character is located above the liquid level L M of the mixed chemical solution of "not open". Also, regions P fine uneven surface treatment is applied, in this example will be located above the liquid level L M of the whole is mixed chemical solution.
Therefore, after the opening of the weak seal portion 12c, the inner surface of the region P on which the fine uneven surface treatment is performed does not come into contact with the chemical solution, and the entire region P appears white and cloudy to the user. In other words, the color of the region P appears to be the same white as the character “not opened”. Therefore, it becomes difficult for the user to visually recognize the letters “not opened” made of white printing applied in the area P which appears to be cloudy white, and as a result, the medical multi-chamber container 10A has been opened. It can be understood that it is.

このような医療用複室容器10Aによれば、使用者は目視するだけで、弱シール部12cが開通されていないことを認識でき、弱シール部12cが未開通で第1薬液と第2薬液とが混合されていないにも関わらず、薬液排出口14から混合前の薬液(この場合は第2薬液のみ)が誤投与されてしまうことを防止できる。また、この医療用複室容器10Aによれば、煩雑な工程や難しい技術を要せずに製造でき、通常の取り扱い方法で使用できるため、取扱性の点も良好である。   According to such a medical multi-chamber container 10A, the user can recognize that the weak seal portion 12c is not opened only by visual observation, and the first chemical solution and the second chemical solution are not opened when the weak seal portion 12c is not opened. In spite of not being mixed, it can prevent that the chemical | medical solution before mixing (in this case only 2nd chemical | medical solution) is accidentally administered from the chemical | medical solution discharge port 14. FIG. Moreover, according to this medical multi-chamber container 10A, since it can manufacture without requiring a complicated process and a difficult technique and can be used with a normal handling method, the point of handleability is also favorable.

そして、さらにこの例では、一対の透明フィルム11a、11bのうち、白色印刷が施された側の透明フィルム11aに、微細凹凸表面処理も施されている。そのため、白色印刷が施されていない側の透明フィルム11bに微細凹凸表面処理が施されている場合に比べて、弱シール部12cの開通後(図2(b))において、使用者は白色印刷の文字をより一層視認しづらくなるという効果も得られる。
しかしながら、白色印刷、微細凹凸表面処理のいずれもが、一対の透明フィルム11a、11bのうちの少なくとも一方に施されていれば、弱シール部12cの開通前には白色印刷を視認でき、開通後には視認しづらくなるという効果を得ることができる。そのため、本発明の医療用複室容器は、白色印刷と微細凹凸表面処理とが同じ側の透明フィルムに施されている形態に限定されない。例えば、白色印刷が一対の透明フィルム11a、11bのうちの一方に施されている場合、この医療用複室容器を正面視した場合に白色印刷を含む領域である限りは、他方の内面に微細凹凸表面処理が施されていてもよい。また、白色印刷および微細凹凸表面処理のいずれもが両方の透明フィルム11a、11bに施されていてもよい。
なお、白色印刷が一対の透明フィルム11a、11bのうちの一方のみに施されている場合には、白色印刷された側の透明フィルムが正面側となるように吊下げて使用することが白色印刷の見易さの点で好ましい。
Further, in this example, among the pair of transparent films 11a and 11b, the fine uneven surface treatment is also applied to the transparent film 11a on the side subjected to white printing. Therefore, compared with the case where the fine uneven surface treatment is applied to the transparent film 11b on the side not subjected to the white printing, the user prints the white printing after the opening of the weak seal portion 12c (FIG. 2B). There is also an effect that it becomes more difficult to visually recognize the characters.
However, if both the white printing and the fine uneven surface treatment are applied to at least one of the pair of transparent films 11a and 11b, the white printing can be visually recognized before the opening of the weak seal portion 12c. Can obtain the effect of being difficult to visually recognize. Therefore, the medical multi-chamber container of the present invention is not limited to a form in which white printing and fine uneven surface treatment are performed on the same transparent film. For example, when white printing is applied to one of the pair of transparent films 11a and 11b, as long as the medical multi-chamber container is viewed from the front, it is fine on the other inner surface as long as the area includes white printing. An uneven surface treatment may be applied. Moreover, both white printing and fine uneven | corrugated surface treatment may be given to both the transparent films 11a and 11b.
When white printing is applied to only one of the pair of transparent films 11a and 11b, it is possible to use the white film by hanging it so that the transparent film on the side on which the white printing is performed is the front side. It is preferable in terms of visibility.

また、この例では、微細凹凸表面処理が施される領域として、図中実線で囲まれた矩形の領域Pを示したが、白色印刷を含む領域である限り、その大きさや形状に特に制限はない。例えば、図3に示すように領域Pよりも広い矩形の領域P’としてもよいし、図4に示すように楕円形の領域P”としてもよい。さらには、一対の透明フィルム11a、11bの少なくとも一方の全体を微細凹凸表面処理が施される領域としてもよい。これらいずれの場合でも、図2の医療用複室容器10Aと同様の効果が得られる。
例えば、一対の透明フィルム11a、11bの少なくとも一方の全体に微細凹凸表面処理が施された場合、弱シール部12cの開通前には、微細凹凸表面処理が施された領域の上部は、通常、第1薬液の液面Lよりも上方に位置することとなる。そのため、弱シール部12cの開通前であっても、その部分は白く曇って見える。しかし、その場合でも、医療用複室容器を正面視した場合における白色印刷の周縁部分は、少なくとも液面Lよりも下方に位置して薬液と接触するため、透明に見える。よって、使用者は白色印刷を問題なく視認できる。一方、弱シール部12cが開通すると、第1薬液と第2薬液とが混合されて混合薬液が調製され、その液面Lは、開通前の第1薬液の液面Lよりも低い位置になる。すると、開通前には透明に見えた白色印刷の周縁部分も混合薬液の液面Lよりも上方に位置するようになり、白く曇って見える。その結果、使用者は、白色印刷を視認しにくくなり、弱シール部12cは開通しているものと理解できる。
In this example, a rectangular region P surrounded by a solid line in the drawing is shown as a region on which fine uneven surface treatment is performed. However, as long as the region includes white printing, there is no particular limitation on the size or shape thereof. Absent. For example, it may be a rectangular region P ′ wider than the region P as shown in FIG. 3, or may be an elliptical region P ″ as shown in FIG. 4. Furthermore, the pair of transparent films 11a and 11b At least one of the entire regions may be a region that is subjected to a fine uneven surface treatment, and in any of these cases, the same effect as the medical multi-chamber container 10A of FIG.
For example, when the fine uneven surface treatment is applied to at least one of the pair of transparent films 11a and 11b, before the opening of the weak seal portion 12c, the upper portion of the region subjected to the fine uneven surface treatment is usually so that the the liquid level L 1 of the first chemical liquid located above. Therefore, even before the opening of the weak seal portion 12c, the portion looks white and cloudy. However, even in this case, the peripheral portion of the white printing in the case where the multi-chamber medical container is viewed from the front, in order to contact the chemical positioned lower than at least the liquid level L 1, appears transparent. Therefore, the user can visually recognize white printing without any problem. On the other hand, when the opening is weak seal portion 12c, the first chemical liquid and the second chemical liquid is being mixed chemical solution is prepared mixing, its liquid level L M, a first position lower than the liquid level L 1 of the liquid medicine prior to opening become. Then, now located above the liquid level L M of the well mixed chemical peripheral portion of the white printing appears transparent before opening looks cloudy white. As a result, it becomes difficult for the user to visually recognize the white print, and it can be understood that the weak seal portion 12c is open.

なお、この例では、白色印刷されるマークとして、弱シール部12cが未開通であることを示す「開通されていません」の文字からなるものを例示したが、未開通であることが理解できるものであれば文字に限定されず、図形であってもよいし、これらを組み合わせたものでもよい。また、文字の種類としても「開通されていません」に限定されず、他の文字でもよいし、図形の種類も、例えば○、×、△などの記号、矢印、図柄やこれらを組み合わせたものなど制限はない。しかしながら、白色印刷に未開通であることを示す文字が含まれると、白色印刷の示す意図が使用者に明確に伝わりやすいために好適である。   In this example, as the mark to be printed in white, the mark made up of the characters “not opened” indicating that the weak seal portion 12c is not opened is illustrated, but it can be understood that the mark is not opened. If it is a thing, it will not be limited to a character, A figure may be sufficient and what combined these may be sufficient. In addition, the character type is not limited to “not open”, but may be other characters, and the graphic type may be, for example, a symbol such as ○, ×, △, an arrow, a pattern, or a combination thereof. There are no restrictions. However, it is preferable that the white print includes characters indicating that it is not opened because the intention of the white print is clearly transmitted to the user.

また、白色印刷は透明フィルム11a、11bの外面または内面のいずれか一方に施されていればよいが、印刷と薬液とが直に接触しない方が薬液へのコンタミネーション抑制の観点から好ましい。よって、透明フィルムの外面(外気と接し、薬液とは接しない側の面)に施されている方が好ましい。   Moreover, although white printing should just be given to any one of the outer surface or inner surface of transparent film 11a, 11b, it is preferable from a viewpoint of the contamination suppression to a chemical | medical solution that printing and a chemical | medical solution do not contact directly. Therefore, it is preferable to be applied to the outer surface of the transparent film (the surface on the side in contact with the outside air but not on the chemical solution).

また、この例においては、容器本体12として、周縁部が剥離不能に融着された対向する一対の矩形の透明フィルム11a、11bからなるものを例示したが、例えば筒状の透明フィルムから形成され、周縁部のうち長手方向の両端部のみが剥離不能に融着された形態のものでもよいし、透明フィルムの形状も矩形に限定されない。   In this example, the container body 12 is exemplified by a pair of opposing rectangular transparent films 11a and 11b whose peripheral portions are fused so as not to be peeled off. However, the container body 12 is formed of, for example, a cylindrical transparent film. And the thing of the form fuse | melted only the both ends of the longitudinal direction among the peripheral parts so that peeling was not possible may be sufficient, and the shape of a transparent film is not limited to a rectangle.

また、透明フィルム11a、11bとしては、可撓性材料からなり、医療用途に使用できるものであれば制限はないが、ポリオレフィン樹脂、ポリアミド樹脂、ポリエステル樹脂、(メタ)アクリル樹脂、塩化ビニル樹脂、塩化ビニリデン樹脂、ポリエーテルサルホン、エチレン−ビニルアルコール共重合体等からなる合成樹脂フィルムが好適である。なかでも、透明性、柔軟性、衛生性に優れ、低コストであることから、ポリオレフィン樹脂が好ましい。
ポリオレフィン樹脂としては、例えば、高密度ポリエチレン、中密度ポリエチレン、高圧法低密度ポリエチレン、直鎖状低密度ポリエチレン、エチレン−酢酸ビニル共重合体等のポリエチレン系樹脂;エチレン−αオレフィンランダム共重合体等のオレフィン系エラストマー;ポリプロピレン、エチレン−プロピレンランダム共重合体、α−オレフィン−プロピレンランダム共重合体等のポリプロピレン系樹脂;環状ポリオレフィン樹脂;これらの混合物;が挙げられる。また、これらの樹脂は、耐熱性向上等を目的として一部架橋されていてもよい。
また、透明フィルム11a、11bは、単層でも多層でもよく、その厚みは、好ましくは50〜1000μm、より好ましくは100〜500μmである。
Further, the transparent films 11a and 11b are not limited as long as they are made of a flexible material and can be used for medical purposes, but polyolefin resins, polyamide resins, polyester resins, (meth) acrylic resins, vinyl chloride resins, A synthetic resin film made of vinylidene chloride resin, polyethersulfone, ethylene-vinyl alcohol copolymer or the like is preferable. Of these, polyolefin resins are preferred because they are excellent in transparency, flexibility, hygiene, and low cost.
Examples of the polyolefin resin include polyethylene resins such as high density polyethylene, medium density polyethylene, high pressure method low density polyethylene, linear low density polyethylene, and ethylene-vinyl acetate copolymer; ethylene-α olefin random copolymer Olefin elastomers; polypropylene resins such as polypropylene, ethylene-propylene random copolymers, α-olefin-propylene random copolymers; cyclic polyolefin resins; and mixtures thereof. Further, these resins may be partially crosslinked for the purpose of improving heat resistance.
Moreover, the transparent films 11a and 11b may be a single layer or a multilayer, and the thickness is preferably 50 to 1000 μm, more preferably 100 to 500 μm.

弱シール部12cの形成方法としては、例えば、容器本体12の内面側を融点や相溶性の異なる複数の樹脂(例えばポリエチレンとポリプロピレンなど)からなる組成物で形成し、高融点の樹脂の溶融温度以下でシールする方法などが挙げられる。その他には、ヒートシールを低温で行い、半溶着状態で弱接着させる方法、弱シール部12cの形成部分に予め電子線等で架橋した可撓性材料を用いる方法、強融着部分を特定の面積割合で発生させるシールバーを用いる方法、2枚の可撓性材料の間に易剥離性の樹脂テープを挟む方法等も挙げられる。
なお、薬液収納室を区画する開通可能な仕切部は、開通前には液密に薬液収納室を区画でき、医療用複室容器の使用直前には開通可能なものであればよく、例えば、樹脂製の仕切り部材などにより構成されたものでもよい。
また、医療用複室容器に形成された薬液収納室の数は、この例のように2つに限定されず、3つ以上であってもよい。
As a method for forming the weak seal portion 12c, for example, the inner surface side of the container body 12 is formed of a composition made of a plurality of resins having different melting points and compatibility (for example, polyethylene and polypropylene), and the melting temperature of the high melting point resin. The method of sealing is mentioned below. In addition, heat sealing is performed at a low temperature and weakly bonded in a semi-welded state, a method using a flexible material previously cross-linked with an electron beam or the like on the weak seal portion 12c formation portion, and a strong fusion portion is specified. Examples include a method using a seal bar generated at an area ratio, and a method in which an easily peelable resin tape is sandwiched between two flexible materials.
In addition, the openable partition section that divides the chemical solution storage chamber may partition the chemical solution storage chamber in a liquid-tight manner before opening, as long as it can be opened immediately before use of the medical multi-chamber container. It may be composed of a resin partition member or the like.
Moreover, the number of the chemical | medical solution storage chambers formed in the medical multi-chamber container is not limited to two as in this example, and may be three or more.

医療用複室容器の一例を示す正面図である。It is a front view which shows an example of a medical multi-chamber container. 図1の医療用複室容器について、(a)弱シール部の開通前、(b)弱シール部の開通後を示す正面図である。It is a front view which shows (a) before opening of a weak seal part and (b) after opening of a weak seal part about the medical multiple-chamber container of FIG. 医療用複室容器の他の一例を示す正面図である。It is a front view which shows another example of a medical multi-chamber container. 医療用複室容器のさらに他の一例を示す正面図である。It is a front view which shows another example of a medical multiple-chamber container.

符号の説明Explanation of symbols

10A:医療用複室容器
11a:透明フィルム
11b:透明フィルム
12a:第1の薬液収納室
12b:第2の薬液収納室
12c:弱シール部(仕切部)
13:吊下げ穴
14:薬液排出口

10A: Medical multi-chamber container 11a: Transparent film 11b: Transparent film 12a: First chemical solution storage chamber 12b: Second chemical solution storage chamber 12c: Weak seal part (partition part)
13: Hanging hole 14: Chemical solution outlet

Claims (2)

対向する一対の透明フィルムから形成され、開通可能な仕切部により区画された複数の薬液収納室が形成された容器本体と、前記複数の薬液収納室のうちの1つに連通して設けられた薬液排出口とを有する医療用複室容器であって、
前記薬液排出口が下方となるように当該医療用複室容器を吊下げた場合に、前記仕切部の開通前には、前記複数の薬液収納室内の各薬液の各液面のうち最も上方に位置する液面よりも下方となり、前記仕切部の開通後には、前記各薬液が混合した混合薬液の液面よりも上方となる領域に、前記一対の透明フィルムのうちの少なくとも一方に白色印刷が施されているとともに、
当該医療用複室容器を正面視した場合に前記白色印刷を少なくとも含む領域に、前記一対の透明フィルムのうちの少なくとも一方の内面に微細凹凸表面処理が施されていることを特徴とする医療用複室容器。
A container main body formed with a plurality of chemical solution storage chambers formed from a pair of opposing transparent films and partitioned by an openable partition, and provided in communication with one of the plurality of chemical solution storage chambers A medical multi-chamber container having a chemical solution outlet,
When the medical multi-chamber container is suspended so that the chemical solution discharge port is downward, before opening the partition portion, the uppermost of the liquid levels of the chemical solutions in the plurality of chemical solution storage chambers White printing is performed on at least one of the pair of transparent films in a region that is lower than the liquid level positioned and is higher than the liquid level of the mixed chemical mixed with each chemical after the partition is opened. As well as
When the medical multi-chamber container is viewed from the front, at least one inner surface of the pair of transparent films is subjected to a fine uneven surface treatment in an area including at least the white printing. Multi-chamber container.
前記白色印刷が施された側の透明フィルムに、前記微細凹凸表面処理が施されていることを特徴とする請求項1に記載の医療用複室容器。   The medical multi-chamber container according to claim 1, wherein the fine uneven surface treatment is applied to the transparent film on the side on which the white printing is performed.
JP2008283603A 2008-11-04 2008-11-04 Medical multi-chamber container Active JP5133849B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2008283603A JP5133849B2 (en) 2008-11-04 2008-11-04 Medical multi-chamber container
PCT/JP2009/005623 WO2010052844A1 (en) 2008-11-04 2009-10-26 Double chamber medical container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008283603A JP5133849B2 (en) 2008-11-04 2008-11-04 Medical multi-chamber container

Publications (2)

Publication Number Publication Date
JP2010110386A true JP2010110386A (en) 2010-05-20
JP5133849B2 JP5133849B2 (en) 2013-01-30

Family

ID=42299442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008283603A Active JP5133849B2 (en) 2008-11-04 2008-11-04 Medical multi-chamber container

Country Status (1)

Country Link
JP (1) JP5133849B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015188630A (en) * 2014-03-28 2015-11-02 テルモ株式会社 medical multi-chamber container
US9809948B2 (en) 2014-05-30 2017-11-07 Komatsu Ltd. Work vehicle control method, work vehicle control device, and work vehicle

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004292041A (en) * 2003-03-28 2004-10-21 Shimizu Pharmaceutical Co Ltd Plastic container
JP2005059853A (en) * 2003-08-11 2005-03-10 Shimizu Pharmaceutical Co Ltd Plastic container
JP3126232U (en) * 2006-08-04 2006-10-19 株式会社大塚製薬工場 Multi-chamber container

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004292041A (en) * 2003-03-28 2004-10-21 Shimizu Pharmaceutical Co Ltd Plastic container
JP2005059853A (en) * 2003-08-11 2005-03-10 Shimizu Pharmaceutical Co Ltd Plastic container
JP3126232U (en) * 2006-08-04 2006-10-19 株式会社大塚製薬工場 Multi-chamber container

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015188630A (en) * 2014-03-28 2015-11-02 テルモ株式会社 medical multi-chamber container
US9809948B2 (en) 2014-05-30 2017-11-07 Komatsu Ltd. Work vehicle control method, work vehicle control device, and work vehicle

Also Published As

Publication number Publication date
JP5133849B2 (en) 2013-01-30

Similar Documents

Publication Publication Date Title
KR101258724B1 (en) Method of reinforcing soft sealing part of multicell container for medical use
JP4463205B2 (en) Medical multi-chamber container and manufacturing method thereof
KR101683098B1 (en) cosmetic pouch
US7293646B2 (en) Plural-chamber container
JP5133849B2 (en) Medical multi-chamber container
CN102202979A (en) Light blocking container with content viewing window and contrast background
JP2011084344A (en) Medical multi-chamber container
JPWO2016104406A1 (en) Plastic package
KR20060104988A (en) Medical container and its using method
JP6817852B2 (en) Medical container
JP2010110385A (en) Medical multi-chamber container
WO2010052844A1 (en) Double chamber medical container
JP2008067848A (en) Medical multi-chamber container
JP5361138B2 (en) Multi-chamber container
JP6817849B2 (en) Medical container
JP4902149B2 (en) container
JP4649854B2 (en) Drug bag
JP4686297B2 (en) Packaging bag having a plurality of storage portions and a plurality of dispensing tools
JP4678187B2 (en) Multi-chamber container
JP5238532B2 (en) Medical multi-chamber container, method for recognizing drug mixture using the same, and multi-chamber container for medical use
JP5456587B2 (en) Medical multi-chamber container, medical multi-chamber container with medicine, and method for producing the medical multi-chamber container
JP2008093366A (en) Method of reinforcing inferior sealing part of multicell container for medical use
JP4497987B2 (en) Medical multi-chamber container
JP4179218B2 (en) Medical container
JP5590634B2 (en) Liquid bag

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110815

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121016

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121108

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151116

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5133849

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250